| Theresa Ann Brooks, MS, OTR/L | |
|
3901 Parkway Cir, Springdale, AR 72762-6362 | |
| (479) 587-1700 | |
| (479) 587-1366 |
| Full Name | Theresa Ann Brooks |
|---|---|
| Gender | Female |
| Speciality | Occupational Therapist |
| Location | 3901 Parkway Cir, Springdale, Arkansas |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1215365622 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 225X00000X | Occupational Therapist | 2016023617 (Missouri) | Secondary |
| 225X00000X | Occupational Therapist | OTR3691 (Arkansas) | Primary |
| Provider Name | Highlands Oncology Group Pa |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1346211323 PECOS PAC ID: 7416976196 Enrollment ID: O20051111000204 |
News Archive
EKF, announces that its Stanbio Chemistry Procalcitonin LiquiColor assay has been FDA cleared with Beckman AU 480, 680 and 5800 clinical chemistry analyzers.
At the upcoming HiMSS 14, the AT Group exhibit, Booth #7384, presents MatrixView demonstrating its new turnkey PACS solution, MatrixView PACStream. The new MatrixView PACStream offering satisfies complex demands that are inherent in the movement and storage of medical imaging records and files.
Medisafe 1 Technologies Corp., a developer of patented technologies that physically prevent unauthorized administration of prescription medications, announced today that the company has engaged in preliminary discussions to launch a pilot of its syringe locking device, with a major hospital in Jerusalem.
Adhering to a Mediterranean-type diet (MedDi) does not appear associated with the time to clinical onset of Huntington disease (phenoconversion), according to a study by Karen Marder, M.D., M.P.H., of Columbia University College of Physicians and Surgeons, New York, N.Y., and colleagues.
Cancer Targeted Technology (CTT), a Seattle-based biotechnology firm focusing on small molecule cancer enzyme inhibitors for the generation of novel diagnostics and therapeutics, today announced that it has signed a Research and License Option Agreement with Bayer Pharma AG, Germany. Under the agreement, CTT will work with Bayer to optimize a novel PET imaging agent based on its unique inhibitor scaffold that recognizes a validated cancer enzyme biomarker.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Theresa Ann Brooks, MS, OTR/L 3901 Parkway Cir, Springdale, AR 72762-6362 Ph: (479) 587-1700 | Theresa Ann Brooks, MS, OTR/L 3901 Parkway Cir, Springdale, AR 72762-6362 Ph: (479) 587-1700 |
News Archive
EKF, announces that its Stanbio Chemistry Procalcitonin LiquiColor assay has been FDA cleared with Beckman AU 480, 680 and 5800 clinical chemistry analyzers.
At the upcoming HiMSS 14, the AT Group exhibit, Booth #7384, presents MatrixView demonstrating its new turnkey PACS solution, MatrixView PACStream. The new MatrixView PACStream offering satisfies complex demands that are inherent in the movement and storage of medical imaging records and files.
Medisafe 1 Technologies Corp., a developer of patented technologies that physically prevent unauthorized administration of prescription medications, announced today that the company has engaged in preliminary discussions to launch a pilot of its syringe locking device, with a major hospital in Jerusalem.
Adhering to a Mediterranean-type diet (MedDi) does not appear associated with the time to clinical onset of Huntington disease (phenoconversion), according to a study by Karen Marder, M.D., M.P.H., of Columbia University College of Physicians and Surgeons, New York, N.Y., and colleagues.
Cancer Targeted Technology (CTT), a Seattle-based biotechnology firm focusing on small molecule cancer enzyme inhibitors for the generation of novel diagnostics and therapeutics, today announced that it has signed a Research and License Option Agreement with Bayer Pharma AG, Germany. Under the agreement, CTT will work with Bayer to optimize a novel PET imaging agent based on its unique inhibitor scaffold that recognizes a validated cancer enzyme biomarker.
› Verified 1 days ago
Taylor Stricklin, Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 956 Mathias Dr, Springdale, AR 72762 Phone: 479-419-9911 | |
Justin Silveira, Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 956 Mathias Dr, Springdale, AR 72762 Phone: 479-419-9911 | |
Bailey Hudson, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 2070 Mckenzie Rd, Springdale, AR 72762 Phone: 479-750-7778 | |
Dr. Moriah Hatfield, OTD, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 2070 Mckenzie Rd Ste C, Springdale, AR 72762 Phone: 479-750-7778 | |
Mrs. Elizabeth Allred Cottrell, MS, OTR L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 403 W Maple Ave, Springdale, AR 72764 Phone: 479-750-6240 Fax: 479-750-6627 | |
Craig Hladun, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 2070 Mckenzie Rd, Suite C, Springdale, AR 72762 Phone: 870-404-3243 | |
Mrs. Nereyda Manatt, Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 956 Mathias Dr, Springdale, AR 72762 Phone: 479-419-9911 |